MNTA – Craig Wheeler said this today on the first-to-file status for generic Copaxone (Sandoz/MNTA submitted the Copaxone ANDA on 12/27/07, the known date of the first ANDA submission from any company):
“Unless there was another company that was working over Christmas and submitted on the 27th, our chances of being the first to file are pretty good.”
The art of the understatement :- )
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”